Dr. Sreekanth S. Raghavan is the President and the Chief Executive Officer. He is a MBBS, DCH, American Board certified in Pediatrics, American Board certified in Pediatric Cardiology, Fellow of the American College of Cardiology.

Designations and experience includes software automation in medicine with digital voice processing, Clinical reporting solutions, and Telemedicine while being an ex Assistant Professor in the University of Toledo (previously. Medical university of Ohio) and clinical consultant pediatric cardiologist at Toledo, Hospitals and Mercy Children’s hospital and Medical College.

Experienced in conducting clinical trials and has IRB approvals for studies such as vascular reactivity in Sickle cell anemia patients and Long QT syndrome assessment.

He has several publications to his credit, published in peer reviewed journals.

He has been an invited speaker in several conferences both in India and in the US.
 


Dr. Rekha T is the Senior Scientist and Chief operating officer of the company. She has a doctorate in genetics and has more than 6 years of clinical research experience.

She has acquired experience in various therapeutic areas including virology and gastroenterology. She also has practical knowledge of molecular biology techniques and has actively been involved in various government funded research projects. She has published papers in national and international journals.

She has extensive experience in many areas governing clinical trials, including clinical monitoring, project and resource management, GCP training and auditing of clinical trials. As a project leader and clinical research manager, she has managed and monitored clinical trials (Phases 1-4) including sponsor-driven studies and trials done in collaboration with large cooperative groups. Dr. Rekha has thorough knowledge of ICH guidelines pertaining to clinical research.
 
 

Mr. T. Neeraj is a B.Pharma graduate and has done Masters in Biotechnology from University of Dundee, Scotland. He is the administrator and clinical validation programmer of the company.

He is presently working for his doctorate on congenital heart Septal Defects. He has 2 years of experience in clinical trials and is well versed with protocol development; CRF design and review; trip report review; budget/contracts, payment and patient tracking; study close-out activities; the analysis and preparation of results for regulatory submission; and compliance with all applicable clinical regulations, GCP/SOP's and company policies.

He has excellent interpersonal skills that are required for working with the study participants.

 
 
 
Design : Pruthvi Cybertech